{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T01:14:07Z","timestamp":1790730847225,"version":"4.1.0"},"reference-count":17,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2000,7,1]],"date-time":"2000-07-01T00:00:00Z","timestamp":962409600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2000,7]]},"DOI":"10.1006\/gyno.2000.5813","type":"journal-article","created":{"date-parts":[[2002,9,17]],"date-time":"2002-09-17T22:50:18Z","timestamp":1032303018000},"page":"28-31","source":"Crossref","is-referenced-by-count":71,"title":["Combination Chemotherapy with Methotrexate, Etoposide, and Actinomycin D for High-Risk Gestational Trophoblastic Tumors"],"prefix":"10.1006","volume":"78","author":[{"given":"Hideo","family":"Matsui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyomi","family":"Suzuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshinori","family":"Iitsuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuyoshi","family":"Seki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Souei","family":"Sekiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1006\/gyno.2000.5813_RF1","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1159\/000009987","article-title":"Comparison of chemotherapies with methotrexate, VP-16 and actinomycin-D in low-risk gestational trophoblastic disease: Remission rates and drug toxicities","volume":"46","author":"Matsui","year":"1998","journal-title":"Gynecol Obstet Invest"},{"key":"10.1006\/gyno.2000.5813_RF2","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1016\/S0002-9378(96)70229-6","article-title":"Treatment of low-risk metastatic gestational trophoblastic tumors with single-agent chemotherapy","volume":"174","author":"Roberts","year":"1996","journal-title":"Am J Obstet Gynecol"},{"key":"10.1006\/gyno.2000.5813_RF3","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1006\/gyno.1994.1169","article-title":"5-Day methotrexate for women with metastatic gestational trophoblastic disease","volume":"54","author":"Soper","year":"1994","journal-title":"Gynecol Oncol"},{"key":"10.1006\/gyno.2000.5813_RF4","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/0002-9378(73)90389-X","article-title":"Treatment of metastatic trophoblastic disease: Good and poor prognosis","volume":"115","author":"Hammond","year":"1973","journal-title":"Am J Obstet Gynecol"},{"key":"10.1006\/gyno.2000.5813_RF5","first-page":"830","article-title":"Treatment of high-risk gestational trophoblastic disease with methotrexate, actinomycin D, and cyclophosphamide chemotherapy","volume":"65","author":"Lurain","year":"1985","journal-title":"Obstet Gynecol"},{"key":"10.1006\/gyno.2000.5813_RF6","first-page":"272","article-title":"Poor prognosis metastatic gestational trophoblastic disease: The prognostic significance of the scoring system in predicting chemotherapy failures","volume":"76","author":"Mortakis","year":"1990","journal-title":"Obstet Gynecol"},{"key":"10.1006\/gyno.2000.5813_RF7","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/0014-2964(80)90359-X","article-title":"Anti-tumor activity of epipodophyllin derivative VP16-213 (etoposide: NSC-141540) in gestational choriocarcinoma","volume":"16","author":"Newlands","year":"1980","journal-title":"Eur J Cancer"},{"key":"10.1006\/gyno.2000.5813_RF8","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1471-0528.1986.tb07815.x","article-title":"Developments in chemotherapy for medium- and high-risk patients with gestational trophoblastic tumours (1979\u20131984)","volume":"93","author":"Newlands","year":"1986","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1006\/gyno.2000.5813_RF9","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1111\/j.1471-0528.1991.tb10369.x","article-title":"Results with the EMA\/CO (etoposide, methotrexate, actinomycin D, cyclophosphamide, vincristine) regimen in high risk gestational trophoblastic tumours, 1979 to 1989","volume":"98","author":"Newlands","year":"1991","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1006\/gyno.2000.5813_RF10","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1200\/JCO.1997.15.7.2636","article-title":"EMA\/CO for high-risk gestational trophoblastic tumors: Results from a cohort of 272 patients","volume":"15","author":"Bower","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1006\/gyno.2000.5813_RF11","first-page":"113","article-title":"Alternating weekly chemotherapy with etoposide\u2013methotrexate\u2013dactinomycin\u2013cyclophosphamide\u2013vincristine for high-risk gestational trophoblastic disease","volume":"83","author":"Soper","year":"1994","journal-title":"Obstet Gynecol"},{"key":"10.1006\/gyno.2000.5813_RF12","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0090-8258(88)80029-5","article-title":"EMA\/CO regimen in high-risk gestational trophoblastic tumor (GTT)","volume":"31","author":"Bolis","year":"1988","journal-title":"Gynecol Oncol"},{"key":"10.1006\/gyno.2000.5813_RF13","first-page":"817","article-title":"Etoposide, methotrexate, actinomycin D, cyclophosphamide, and vincristine for the treatment of metastatic, high-risk gestational trophoblastic disease","volume":"80","author":"Schink","year":"1992","journal-title":"Obstet Gynecol"},{"key":"10.1006\/gyno.2000.5813_RF14","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/j.1479-828X.1994.tb01047.x","article-title":"EMACO in high risk gestational trophoblast disease: The Australian experience","volume":"34","author":"Quinn","year":"1994","journal-title":"Aust NZ J Obstet Gynaecol"},{"key":"10.1006\/gyno.2000.5813_RF15","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1006\/gyno.1996.4534","article-title":"The management of gestational trophoblastic tumors with etoposide, methotrexate, and actinomycin D","volume":"64","author":"Soto-Wright","year":"1997","journal-title":"Gynecol Oncol"},{"key":"10.1006\/gyno.2000.5813_RF16","first-page":"677","article-title":"20 years' experience in chemotherapy of choriocarcinoma and malignant mole","volume":"92","author":"Sung","year":"1979","journal-title":"Chin Med J"},{"key":"10.1006\/gyno.2000.5813_RF17","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1200\/JCO.1996.14.10.2769","article-title":"Combination but not single-agent methotrexate chemotherapy for gestational trophoblastic tumors increases the incidence of second tumors","volume":"14","author":"Rustin","year":"1996","journal-title":"J Clin Oncol"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009082580095813X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009082580095813X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,8]],"date-time":"2019-05-08T07:29:30Z","timestamp":1557300570000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S009082580095813X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,7]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2000,7]]}},"alternative-id":["S009082580095813X"],"URL":"https:\/\/doi.org\/10.1006\/gyno.2000.5813","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2000,7]]}}}